Wednesday, 20 August 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 20 August 2025
News

Ex-Roche drug short deepens

Posted 14 August 2025 PM

Echo Therapeutics is working hard to maintain supply of Pegasys, the hepatitis treatment it assumed sponsorship of from Roche in 2022.

The Sydney-based pharmaceutical distribution company started in 2018 by former Roche Director, Jude D’Silva, has notified the TGA that it expects shortages of Pegasys injection pre-filled syringes in both 180 and 135 microgram strengths to continue until December 2025, citing “changes in manufacturing sites and supply constraints due to global shortages”.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (14)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.